Atlas Trials

A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial

Clinical trial NCT05946564 · RECRUITING

Trial details

NCT number
NCT05946564
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
ANCA Associated VasculitisRapidly Progressive GlomerulonephritisCrescentic Glomerulonephritis
Start date
2023-10-24
Primary completion
2028-04-24
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.